Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Ebumab Sandbox ApS
APS
Active
Advertising protection
CVR 43575627
Ole Maaløes Vej 3, 2200
København N
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2022 · 3 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
Ebumab Sandbox ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
DKK millions
0M
0M
0M
-1M
-1M
0M
2023
0M
0%
2024
0M
0%
2025
EBITDA
DKK millions
0M
0M
0M
-1M
-1M
0M
2023
0M
0%
2024
0M
0%
2025
Income statement
DKK thousands
Item
2023
2024
2025
Revenue
0
-10
-13
Staff expenses
-0
-0
-0
EBITDA
-6
-10
-13
Depreciation & amort.
-0
-0
-0
EBIT
-6
-10
-13
Net financials
0
0
1
Profit before tax
-6
-10
-12
Tax
-0
-2
-0
Net profit
-6
-8
-11
Balance sheet
DKK thousands
Item
2023
2024
2025
Total assets
34
26
15
Equity
34
26
15
Long-term debt
0
0
0
Short-term debt
0
0
0
Total debt
0
0
0
Financial ratios
5-year trend
EBITDA margin
-1263000.0%
This company
15.8%
Market median
7993771% below market
2023
2025
Equity ratio
100.0%
This company
38.2%
Market median
162% above market
2023
2025
Return on equity
-73.4%
This company
18.4%
Market median
499% below market
2023
2025
Net profit margin
-1115000.0%
This company
8.1%
Market median
13765532% below market
2023
2025
Asset turnover
-0.83×
This company
1.12×
Market median
174% below market
2023
2025
Debt / equity
0.00×
This company
0.62×
Market median
100% below market
2023
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2022-10-12 – 2023-12-31
View
PDF
More on Ebumab Sandbox ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
